SLU-PP-332 500 mcg

Buy Dragon Pharma SLU-PP-332 500 mcg – Advanced Mitochondrial Peptide

Dragon Pharma SLU-PP-332 delivers 500 mcg of a promising PPARδ (Peroxisome Proliferator-Activated Receptor Delta) agonist per tablet, developed for research into metabolic enhancement, endurance, and mitochondrial efficiency. This experimental compound mimics the effects of endurance training by optimizing the way the body burns fat for fuel — making it a novel agent in physique enhancement and athletic performance strategies.

What Is SLU-PP-332?

SLU-PP-332 is a synthetic peptidomimetic developed to stimulate PPARδ activity — the same pathway targeted by GW501516 (Cardarine). Unlike traditional PPARδ agonists, SLU-PP-332 was designed with improved selectivity and potentially fewer carcinogenic risks, making it a more favorable research candidate. According to recent studies published on PubMed, SLU-PP-332 promotes mitochondrial biogenesis, shifts substrate utilization toward fatty acids, and increases VO2 max in animal models.

Benefits of SLU-PP-332 for Athletes

• Enhances fatty acid oxidation (fat as fuel)
• Improves endurance without traditional cardio
• Supports mitochondrial health and function
• May aid in preserving muscle while dieting
• No stimulant side effects

These effects make SLU-PP-332 particularly appealing to bodybuilders during cutting cycles, endurance athletes looking to boost VO2 max, or those recovering from metabolic suppression.

SLU-PP-332 Dosage and Application

Due to its experimental status, human dosage data is limited. However, based on early research trends, users have explored dosing in the 500 mcg to 1 mg per day range, taken orally. A conservative research cycle may last 4–6 weeks.

How to Stack SLU-PP-332 Effectively

For fat loss goals, SLU-PP-332 pairs well with GW501516 (Cardarine) 20 mg or Clenbuterol 40 mcg for synergistic fat-burning results. It can also be used alongside Semaglutide 5 mg to control appetite and metabolic output.

Users prioritizing muscle preservation may stack with MK-677 (Ibutamoren) for GH support or BPC-157 for recovery and healing.

Side Effects and Considerations

SLU-PP-332 is a research chemical, and long-term safety data in humans is not yet available. So far, animal studies suggest it is well-tolerated without the carcinogenic concerns associated with GW501516, but users should exercise caution and avoid prolonged use without guidance.

Why Choose Dragon Pharma SLU-PP-332?

Dragon Pharma's SLU-PP-332 is third-party tested for content accuracy, offering 500 mcg per tablet in a convenient oral format. For those seeking cutting-edge metabolic modulation, SLU-PP-332 represents the next generation of PPARδ research tools — ideal for bodybuilders, biohackers, and athletes.

Browse our complete range of Dragon Pharma performance enhancers for more advanced research compounds.

Frequently Asked Questions